S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
ATOS · Atossa Therapeutics, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Atossa Therapeutics Inc (ATOS)
NASDAQ NMS - GLOBAL MARKET
Biotechnology
$2.54
-0.03
(-1.17%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$2.54
$2.38
$2.56
52-WEEK RANGE
$2.54
$1.70
$15.22
What's happening
- ATOS is down 1.17% today, trading at $2.54. — Live quote
- Volume today (4,010) is well below its 3-month average of 119,690. (Finnhub fundamentals)
- Reports earnings on 2026-11-10, 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.95 actual vs. $-1.05 estimated (+9.1%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 2
Buy 5
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (8 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
ATOS
-71.30%
vs S&P 500
-84.08%
1-YEAR RETURN
ATOS
-83.23%
vs S&P 500
-97.80%
6-MONTH RETURN
ATOS
-55.98%
3-MONTH RETURN
ATOS
+5.83%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.95
Est. $-1.05
BEAT +9.1%
2026-04-26 (Q1 2026)
$-1.11
Est. $-6.25
BEAT +82.2%
2026-01-26 (Q4 2025)
$-3.08
Est. $-1.16
MISS -165.4%
2025-10-26 (Q3 2025)
$-1.05
Est. $-1.02
MISS -2.9%
Valuation Measures & Ratios
Enterprise Value4-$571.9K
Forward P/E5—
PEG Ratio6-0.02
Price / Sales (TTM1)159.51
Price / Book70.72
EV4 / Revenue-3.57
EV4 / EBITDA—
Profit Margin-7412.50%
Operating Margin-7412.50%
Return on Equity (ROE8)-102.99%
Return on Assets (ROA9)-85.78%
Avg Volume (3M)119,690
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $17.4M | $43.8M | $1.08B | $36.5M | $29.0M |
| P/E | -0.50 | -1.31 | -34.70 | -1.29 | -1.12 |
| Price/Book | 0.65 | 1.44 | 21.65 | 0.63 | 0.44 |
| ROE | -131.18% | -109.63% | -62.39% | -49.26% | -39.61% |
| ROA | -109.03% | -88.08% | -53.55% | -44.05% | -36.57% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short788,334
Change from Prior Settlement+3.43%
% of Float—
Days to Cover (Short Ratio)11.31
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 8-K, filed 2026-10-09; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -7412.5%. Finnhub fundamentals ↗
- Trailing 52-week price return is -83.2%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on ATOS
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$8.7M | -$9.9M | -$9.3M | -$9.0M | -$7.4M | -$6.4M | -$7.1M | -$7.0M |
| Net income | -$8.5M | -$9.6M | -$8.7M | -$8.4M | -$6.7M | -$7.2M | -$6.0M | -$5.9M |
| EPS (diluted) | $-0.95 | $-1.11 | $-0.07 | $-0.98 | $-0.78 | $-0.06 | $-0.05 | $-0.05 |
| EPS (basic) | $-0.95 | $-1.11 | $-0.07 | $-0.98 | $-0.78 | $-0.06 | $-0.05 | $-0.05 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $32.3M | $37.9M | $47.6M | $58.0M | $64.5M | $70.7M | $76.4M | $79.5M |
| Total liabilities | $5.5M | $7.5M | $8.3M | $8.2M | $6.8M | $5.4M | $5.0M | $5.8M |
| Stockholders' equity | $26.8M | $30.5M | $39.4M | $49.8M | $57.7M | $65.3M | $71.5M | $73.7M |
| Total current assets | $31.0M | $36.7M | $45.6M | $55.7M | $62.5M | $68.7M | $74.5M | $77.1M |
| Total current liabilities | $5.5M | $7.5M | $8.3M | $8.2M | $6.8M | $5.4M | $5.0M | $5.8M |
| Cash & equivalents | $26.1M | $31.7M | $41.3M | $51.8M | $57.9M | $65.1M | $71.1M | $74.8M |
| Accounts receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Other current assets | — | — | — | — | — | — | — | — |
| Property, plant & equipment | — | — | — | — | — | — | — | — |
| Intangible assets | — | — | — | — | — | — | — | — |
| Other non-current assets | $1.3M | $1.3M | $2.0M | $2.3M | $2.0M | $2.0M | $2.0M | $2.4M |
| Accounts payable | $2.0M | $2.6M | $4.3M | $3.5M | $2.0M | $1.2M | $679.0K | $1.6M |
| Accrued liabilities | $1.4M | $2.8M | $1.3M | $2.0M | $2.2M | $1.8M | $919.0K | $1.7M |
| Other current liabilities | $1.1M | $1.1M | $1.1M | $1.6M | $1.6M | $1.5M | $1.5M | $1.5M |
| Common stock & paid-in capital | $1.8M | $1.6M | $1.6M | $23.5M | $23.5M | $23.5M | $1.6M | $22.9M |
| Retained earnings | -$264.6M | -$256.2M | -$246.6M | -$235.6M | -$226.9M | -$218.5M | -$211.8M | -$205.4M |
| Accumulated other comprehensive income (loss) | — | — | — | — | — | — | — | — |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$9.6M | -$9.6M | -$10.5M | -$6.0M | -$7.3M | -$6.0M | -$7.1M | -$4.8M |
| Investing cash flow | $0 | $0 | -$7.0K | -$7.0K | $0 | -$9.0K | $0 | -$10.0K |
| Financing cash flow | $4.0M | $0 | $0 | $0 | $0 | $0 | $3.4M | $0 |
| Free cash flow | -$9.6M | -$9.6M | -$10.5M | -$6.0M | -$7.3M | -$6.0M | -$7.1M | -$4.8M |
| Capital expenditures | $0 | $0 | $7.0K | $7.0K | $0 | $9.0K | $0 | $10.0K |
| Depreciation & amortization | — | — | — | — | — | — | — | — |
| Share-based compensation | $815.0K | $722.0K | $503.0K | $784.0K | $796.0K | $563.0K | $774.0K | $749.0K |
| Change in accounts receivable | — | — | — | — | — | — | — | — |
| Change in inventory | — | — | — | — | — | — | — | — |
| Change in accounts payable | -$593.0K | -$1.7M | $761.0K | $1.5M | $845.0K | $486.0K | -$882.0K | $505.0K |
| Share repurchases | — | — | — | — | — | — | $0 | — |
| Tax withholding on stock comp | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Gross profit | — | — | — | — | — |
| Operating income | -$37.1M | -$27.6M | -$31.4M | -$27.7M | -$20.5M |
| Net income | -$34.8M | -$25.5M | -$30.1M | -$27.0M | -$20.6M |
| EPS (diluted) | $-4.04 | $-3.04 | $-0.24 | $-0.21 | — |
| EPS (basic) | $-4.04 | $-3.04 | $-0.24 | $-0.21 | $-0.18 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $47.6M | $76.4M | $96.3M | $123.5M | $141.3M |
| Total liabilities | $8.3M | $5.0M | $5.2M | $5.6M | $3.1M |
| Stockholders' equity | $39.4M | $71.5M | $91.0M | $118.0M | $138.1M |
| Total current assets | $45.6M | $74.5M | $92.2M | $118.2M | $141.2M |
| Total current liabilities | $8.3M | $5.0M | $5.2M | $5.6M | $3.1M |
| Cash & equivalents | $41.3M | $71.1M | $88.5M | $110.9M | $136.4M |
| Accounts receivable | — | — | — | — | — |
| Inventory | — | — | — | — | — |
| Other current assets | — | — | — | $2.4M | $1.2M |
| Property, plant & equipment | — | — | — | — | $20.0K |
| Intangible assets | — | — | — | — | $54.0K |
| Other non-current assets | $2.0M | $2.0M | $2.3M | $635.0K | $22.0K |
| Accounts payable | $4.3M | $679.0K | $806.0K | $3.0M | $1.7M |
| Accrued liabilities | $1.3M | $919.0K | $973.0K | $1.1M | $204.0K |
| Other current liabilities | $1.1M | $1.5M | $1.8M | $19.0K | $21.0K |
| Common stock & paid-in capital | $1.6M | $1.6M | $22.8M | $22.8M | $22.8M |
| Retained earnings | -$246.6M | -$211.8M | -$186.3M | -$156.2M | -$129.2M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$29.8M | -$21.0M | -$20.9M | -$20.8M | -$16.5M |
| Investing cash flow | -$23.0K | -$19.0K | -$14.0K | -$4.7M | -$9.0K |
| Financing cash flow | $0 | $3.7M | -$1.5M | $0 | $113.3M |
| Free cash flow | -$29.8M | -$21.0M | -$21.0M | -$20.8M | -$16.5M |
| Capital expenditures | $23.0K | $19.0K | $14.0K | $27.0K | $9.0K |
| Depreciation & amortization | — | — | — | $8.0K | $23.0K |
| Share-based compensation | $2.6M | $2.3M | $4.6M | $6.8M | — |
| Change in accounts receivable | — | — | — | — | — |
| Change in inventory | — | — | — | — | — |
| Change in accounts payable | $3.6M | -$127.0K | -$2.2M | $1.2M | $128.0K |
| Share repurchases | — | $0 | $1.5M | $0 | — |
| Tax withholding on stock comp | — | — | — | $0 | $573.0K |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding ATOS as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-03-26 to 2026-05-12
Recent transactions
- Most recent: Steinhart Richard I (Reporting person) — Grant / award of 10,000 shares on 2026-05-12.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Steinhart Richard I | Reporting person | Grant / award | 2026-05-12 | 10,000 |
| Chen Shu-Chih | Reporting person | Grant / award | 2026-05-12 | 10,000 |
| Remmel H. Lawrence | Reporting person | Grant / award | 2026-05-12 | 10,000 |
| Finn Jonathan | Reporting person | Grant / award | 2026-05-12 | 10,000 |
| Galli Stephen J | Reporting person | Grant / award | 2026-05-12 | 10,000 |
| Cigler Tessa | Reporting person | Grant / award | 2026-05-12 | 10,000 |
| QUAY STEVEN C | President & CEO | Grant / award | 2026-03-27 | 65,000 |
| Daniel Mark James | Chief Financial Officer | Grant / award | 2026-03-26 | 63,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-05-12 | Steinhart Richard I | Reporting person | Grant / award | 10,000 | $0.00 |
| 2026-05-12 | Chen Shu-Chih | Reporting person | Grant / award | 10,000 | $0.00 |
| 2026-05-12 | Remmel H. Lawrence | Reporting person | Grant / award | 10,000 | $0.00 |
| 2026-05-12 | Finn Jonathan | Reporting person | Grant / award | 10,000 | $0.00 |
| 2026-05-12 | Galli Stephen J | Reporting person | Grant / award | 10,000 | $0.00 |
| 2026-05-12 | Cigler Tessa | Reporting person | Grant / award | 10,000 | $0.00 |
| 2026-03-27 | QUAY STEVEN C | President & CEO | Grant / award | 65,000 | $0.00 |
| 2026-03-26 | Daniel Mark James | Chief Financial Officer | Grant / award | 63,000 | $0.00 |
| 2026-01-20 | QUAY STEVEN C | President & CEO | Grant / award | 325,203 | $0.00 |
| 2025-05-21 | QUAY STEVEN C | President & CEO | Open market purchase | 11,239 | $0.88 |
| 2025-03-26 | Remmel H. Lawrence | Reporting person | Open market purchase | 10,000 | $0.70 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 23:46 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-09 | 8-K | 2026-10-08 | View on SEC.gov → |
| 2026-09-29 | 8-K | 2026-09-29 | View on SEC.gov → |
| 2026-09-18 | 8-K | 2026-09-18 | View on SEC.gov → |
| 2026-08-07 | 8-K | 2026-08-07 | View on SEC.gov → |
| 2026-08-07 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-06-11 | 8-K | 2026-06-10 | View on SEC.gov → |
| 2026-05-14 | 4 | 2026-05-12 | View on SEC.gov → |
| 2026-05-14 | 4 | 2026-05-12 | View on SEC.gov → |
| 2026-05-14 | 4 | 2026-05-12 | View on SEC.gov → |
| 2026-05-14 | 4 | 2026-05-12 | View on SEC.gov → |
| 2026-05-14 | 4 | 2026-05-12 | View on SEC.gov → |
| 2026-05-14 | 4 | 2026-05-12 | View on SEC.gov → |
Recent news
Headlines about ATOS (Atossa Therapeutics, Inc.). Links open the publisher — we don’t host full articles.
-
Atos Group 2026 Q3 - Results - Earnings Call Presentation (OTCMKTS:AEXAY) 2026-10-21
Seeking Alpha · 2026-10-21 -
Atos shares jump 13% to five-week high as €7 mln bond buyback comes into focus
Investing.com · 2026-10-21 -
Earnings call transcript: Atos Group shares jump on Q3 cash flow turnaround
Investing.com Canada · 2026-10-21 -
Atos Group (ATO.PA) stock price, news, quote and history
Yahoo Finance Singapore · 2026-10-20 -
Number of shareholders of Atossa Therapeutics, Inc. – FWB:YAG
TradingView · 2026-10-20 -
Atos Completes Digital Workplace Overhaul for 30,000 Orange Business Employees
Idéal Investisseur · 2026-10-20 -
Fortinet (FTNT) Expands Its Atos Partnership, Is The Stock 37% Overvalued?
Simply Wall Street · 2026-10-19 -
Atossa Therapeutics, Inc. (ATOS) stock price, news, quote and history
Yahoo Finance Singapore · 2026-10-19
No headlines in this category right now — try “All”.